Arjuna for Heart Health

Research suggests that Terminalia arjuna bark, a traditional Ayurvedic remedy, may offer cardiovascular benefits, with the available evidence drawing from one small randomized, double-blind, placebo-controlled trial and two review or analytical studies. The clinical trial found that a standardized bark extract produced a statistically significant improvement in left ventricular ejection fraction — a measure of how well the heart pumps blood — along with reductions in fatigue and markers of cardiac workload in healthy adults over eight weeks, with no reported adverse events. Studies indicate that these effects are likely attributable to the bark's rich polyphenol content, particularly proanthocyanidins and catechins chemically similar to those found in tea. The overall body of evidence is supportive in direction but limited in scope, as the single clinical trial involved a relatively small, healthy population over a short timeframe, meaning findings may not generalize to those with existing heart conditions or longer-term use.